Thorax / Lung Basic Science Conference 12/21/2005 J.R. Nitzkorski.

Slides:



Advertisements
Similar presentations
The BIG Kahuna among Tumors
Advertisements

Treatment.
STAGING OF BRONCHOGENIC CA NSCLC STAGING TNM CLASSFICATION Adenocarcinoma Squamous cell carcinoma Large cell carcinoma T – Primary tumor N – Regional.
Ca lung Dr. D.P. Singh Professor, Surgery.. Primary lung cancer – risk factors Cigarette smoking Number of years Number of packs Passive smoking Atmospheric.
Lung Cancer Non-Small Cell Staging/Prognosis/Treatment Oncology Teaching October 14, 2005 Lorenzo E Ferri.
A Slide Presentation for Oncology Nurses
Radiological Category: Case Report Submitted by:Matthew Bean MSIV Faculty reviewer:Sandra Oldham M.D Date accepted: August 28, 2014 Principal Modality.
Pleural Tumors Classified as primary and secondary tumors . Primary Pleural tumors are Mesotheiloma which may be 1-Localized benign 2- Diffuse Malignant.
Rowa’ al Ramahi 1.  Lung carcinomas arise from normal bronchial epithelial cells that have acquired multiple genetic lesions and are capable of expressing.
Lung Cancer Bio 218, Fall Bio 218 Fall
LUNG CANCER..... NIMI-HART PHILIP PREMED DEFINITION EPIDEMIOLOGY TYPES CAUSES SIGNS AND SYMPTOMS STAGING DIAGNOSIS TREATMENT PROGNOSIS PREVENTION.
“No Air” Management of Lung Cancer
Vinni Swad Zander Thompson
Carcinoma Lung.
Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.
Metastatic involvement (M) M0 - No metastases M1 - Metastases present.
Primary Bronchogenic Carcinoma (LUNG CANCER) SHEN JIN The First Affiliated Hospital of Kunming Medical College.
Myndrannsóknir á lungum Lungnakrabbamein Jørgen Albrechtsen, röntgenlæknir.
By: Ashleen Atchue and Mario Tovar
Lung cancer and pulmonary nodules Resident’s seminar 02/01/2006 Elsa B. Valsdottir.
LUNG CANCER (Bronchogenic Carcinoma)
Colorectal cancer in Norway Maria Mai Ingvild Hvalby.
Lung Cancer Overview MaXiaoBiao Yun nan biotherapy center.
Computed Tomography Contrast-enhanced helical CT of the thorax and abdomen that includes the liver and adrenal glands is the standard radiologic investigation.
Breast Cancer Nick Settecase, Payton Picone, & Mike Malone.
Colorectal cancer Khayal AlKhayal MD,FRCSC
Pulmonary Neoplasia Prof. Frank Carey. Lung Neoplasms r Primary l benign (rare) l malignant (very common) r Metastatic (Very common)
Update on 18 F-Fluorodeoxyglucose/Positron Emission Tomography and Positron Emission Tomography/ Computed Tomography Imaging of Squamous Head and Neck.
BRONCHIAL TUMOURS. Bronchial tumours, widely divided in to primary lung tumours and secondary or metastatic cancer. The majority of primary lung tumour.
Lung Cancer Hassan Ghobadi MD, Pulmonologist
Terminology of Neoplasms and Tumors  Neoplasm - new growth  Tumor - swelling or neoplasm  Leukemia - malignant disease of bone marrow  Hematoma -
Lung Cancer MODULE G1 Chapter 26, pp
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero,
Computed tomography scan of the abdomen shows a large cystic mass in the abdomen and pelvis without solid tissue or septations (measurement: 43×20×31-cm.
Thoracic Surgery By Mike Poullis.
SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,
PRESENTING LUNG CANCER. Lung Cancer: Defined  Uncontrolled growth of malignant cells in one or both lungs and tracheo-bronchial tree  A result of repeated.
Chapter 28 Lung Cancer. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Objectives  Describe the epidemiology of.
LUNG CANCER Dr.Mohammadzadeh. Lung cancer is the leading cancer killer in the United States. Every year, it accounts for 30% of all cancer deaths— more.
Lung Cancer in 2011 Dr. Natasha Leighl, MD MMSc FRCPC Medical Oncologist, Princess Margaret Hospital Assistant Professor, Medicine, University of Toronto.
WHAT ARE THE RISK FACTORS FOR LUNG CANCER? SMOKING.
 Cancer is a group of more than 100 diseases that develop over time › Involve the uncontrolled division of the body’s cells  Cancer is the 2 nd leading.
T1: Tumor 2.0 cm or less in greatest dimension
Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and.
Bronchogenic Carcinoma. most commonly diagnosed cancer worldwide most common cause of cancer death in both men and women Lung cancer kills more people.
Cancer Notes. What is cancer? Cancer develops when cells in the body begin to grow out of control.
BRONCHOIAL TUMOURS.
Taipei VGH Practice Guidelines: Oncology Guidelines Index Cancer of Lung Version Table of Content StagingStaging, ManuscriptManuscript Taipei Veterans.
A Pictorial Guide to the Revised Staging System for Non-Small Cell Lung Cancer Through the Use of PET/CT Bruno P. Soares, MD; Katherine Zukotynski, MD;
LUNG CANCER DR HUDA BADRI. OVERVIEW OF SESSION Learning objectives Quiz Tutorial on lung cancer and guidelines 15 minutes break Case studies 10minutes.
Breast Cancer 1. Leukemia & Lymphoma New diagnoses each year in the US: 112, 610 Adults 5,720 Children 43,340 died of leukemia or lymphoma in
IMAGING FINDINGS - The NSCLC stage classification is based on the TNM system: - T: extent of the primary tumor - N: extent of regional lymph node involvement.
Adjuvant and Neoadjuvant Therapy in Non- Small Cell Lung Cancer Seminars in Oncology 2oo5;32 (suppl 2):S9-S15 Kyung Hee Medical Center Department of Thoracic.
Lung Cancer WHAT IT IS & WHAT YOU NEED TO KNOW. What is lung cancer? 2 types: 1. Non-small cell lung cancer (NSCLC). 85% of cases 2. Small cell lung cancer.
Lung cancer Gene Kukuy, MD Cardiothoracic Surgery.
 Lung Cancer Sydney Freedman and Rachel Rea. Causes  No exact cause  Smokers and non-smokers can get lung cancer  Smoke causes cancer by damaging.
Instructor Kathleen Gamblin, RN, BSN, OCN Oncology Nurse Navigator
The Uganda Cancer Institute Experience Walusansa Victoria.
CT and PET imaging in non-small cell lung cancer
Ductal Carcinoma (Breast Cancer)
Prognosis of younger patients in non-small cell lung cancer
LUNG CARCINOMA (BRONCHIAL CARCINOMA)
Lung Cancer Screening:
Carcinomas of lung By: Shefaa’ Qa’qa’.
Common Cancers.
The Nuances of Staging Lung cancer Gerard A
Pulmonary nodules discovered on CT scan of the chest
Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?  Kemp H Kernstine, MD, PhD, Kelley A McLaughlin,
Figure 12a Pitfalls in N staging at CT and PET
Presentation transcript:

Thorax / Lung Basic Science Conference 12/21/2005 J.R. Nitzkorski

Sponsored by Joe

1. The most common cause of cancer death (US) in men is: 1.Prostate cancer 2.Lung cancer 3.Colorectal cancer 4.Mesothelioma 5.Leukemia

1. The most common cause of cancer death (US) in men is: 1.Prostate cancer 2.Lung cancer Lung cancer death rate vastly surpasses that of other cancers in men, however reached a peak in 1990 and is trending downward 3.Colorectal cancer 4.Mesothelioma 5.Leukemia

2. The most common cause of cancer death (US) in women is: 1.Breast cancer 2.Lung cancer 3.Colorectal cancer 4.Mesothelioma 5.Leukemia

2. The most common cause of cancer death (US) in women is: 1.Breast cancer 2.Lung cancer More women die from lung cancer than breast cancer, although breast cancer is more common than lung cancer. Heart disease remains the number one overall cause of death. 3.Colorectal cancer 4.Mesothelioma 5.Leukemia

3. Lung cancer develops in what percentage of smokers 1.20% 2.40% 3.60% 4.80%

3. Lung cancer develops in what percentage of smokers 1.20% It also develops in some people with no exposure to cigarettes/occupational exposure, suggesting a genetic predisposition (especially in those less than 50) 2.40% 3.60% 4.80%

4. The correct distribution of small cell lung cancer (SCLC) to non-small cell lung cancer (NSCLC) is 1.80 SCLC : 20 NSCLC 2.50 SCLC : 50 NSCLC 3.20 SCLC : 80 NSCLC 4.10 SCLC : 90 NSCLC 5.2 SCLC : 98 NSCLC

4. The correct distribution of small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) is 1.80 SCLC : 20 NSCLC 2.50 SCLC : 50 NSCLC 3.20 SCLC : 80 NSCLC Although these represent two different histologic and clinical entities, some tumors have admixtures of cell types, suggesting a possible common origin for all lung cancers 4.10 SCLC : 90 NSCLC 5.2 SCLC : 98 NSCLC

5. Name the subdivisions of non-small cell lung cancer (NSCLC): 1._______________ 2._______________ 3._______________

5. Name the subdivisions of non-small cell lung cancer (NSCLC): 1.Squamous cell 2.Adenocarcinoma 3.Large cell

6. Match the histologic cell type with the correct frequency (%) 1.Large cell 2.Adenocarcinoma 3.Squamous cell 4.Small cell

6. Match the histologic cell type with the correct frequency (%) 1.Large cell 2.Adenocarcinoma 3.Squamous cell 4.Small cell

7. Patient with a centrally located lung tumor is most likely to have a: 1.Adenocarcinoma 2.Squamous cell 3.Carcinoid 4.Large cell carcinoma

7. Patient with a centrally located lung tumor is most likely to have a: 1.Adenocarcinoma 2.Squamous cell Squamous cell carcinomas usually arise from the main, lobar, or segmental bronchi, however 1/3 can occur in the small bronchi of lung tissue. Symptoms = hemoptysis, atelectasis, post- obstructive pneumonia Diagnosis = bronchoscopy 3.Carcinoid 4.Large cell carcinoma

8. Patient with a peripherally located lung tumor is most likely to have a: 1.Adenocarcinoma 2.Squamous cell 3.Carcinoid 4.Large cell carcinoma

8. Patient with a peripherally located lung tumor is most likely to have a: 1.Adenocarcinoma Adenocarcinomas usually arise peripherally within the pulmonary parenchyma. Symptoms = pain related to invasion of chest wall, spine, brachial plexus. Diagnosis = percutaneous 2.Squamous cell 3.Carcinoid 4.Large cell carcinoma

9. Regarding NSCLC, the percentage of patients who present with disseminated disease is _____% Of those without disseminated disease, the percentage of patients who present with locally advanced / unresectable cancer is _____%

9. Regarding NSCLC, the percentage of patients who present with disseminated disease is 50% Of those without disseminated disease, the percentage of patients who present with locally advanced / unresectable cancer is 20%

10. Surgery is generally the accepted treatment for NSCLC with the following stages (more than 1) 1.Stage Ia and b 2.Stage IIa 3.Stage IIb 4.Stage IIIa 5.Stage IIIb 6.Stage IV

10. Surgery is generally the accepted treatment for NSCLC with the following stages (more than 1) 1.Stage Ia and b - surgery 2.Stage IIa - surgery 3.Stage IIb - surgery 4.Stage IIIa – surgery, usually after chemo/xrt 5.Stage IIIb – chemo/xrt, poss surgery after chemo/xrt 6.Stage IV - chemo

For reference:

11. On CT, a lymph node _____ cm or less is usually considered to be benign, whereas a lymph node greater than _____ cm is usually considered to be malignant

11. On CT, a lymph node 1.0 cm or less is usually considered to be benign, whereas a lymph node greater than 1.5 cm is usually considered to be malignant** **Co-morbid pulmonary disease and/or post- obsructive pneumonia may cause significant lymphadenopathy without metastasis

12. False-positive lymph node detection on FDG- PET scanning commonly results from: 1.________________________ 2.________________________

12. False-positive lymph node detection on FDG- PET scanning commonly results from: 1.Granulomatous disease 2.Histoplasmosis

13. The modality of choice to confirm FDG-PET positive mediastinal lymphadenopathy with a tissue diagnosis: 1.________________________

13. The modality of choice to confirm FDG-PET positive mediastinal lymphadenopathy with a tissue diagnosis: 1.Mediastinoscopy